Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results.
Dimitrios TsiachrisNikos ArgyriouPanagiotis TsioufisChristos-Konstantinos AntoniouAggeliki LainaGeorgios OikonomouIoannis DoundoulakisAthanasios KordalisKyriakos DimitriadisChristos-Konstantinos AntoniouKonstantinos TsioufisPublished in: Journal of cardiovascular development and disease (2024)
Atrial fibrillation has progressively become a more common reason for emergency department visits, representing 0.5% of presenting reasons. Registry data have indicated that about 60% of atrial fibrillation patients who present to the emergency department are admitted, emphasizing the need for more efficient management of atrial fibrillation in the acute phase. Management of atrial fibrillation in the setting of the emergency department varies between countries and healthcare systems. The most plausible reason to justify a conservative rather than an aggressive strategy in the management of atrial fibrillation is the absence of specific guidelines from diverse societies. Several trials of atrial fibrillation treatment strategies, including cardioversion, have demonstrated that atrial fibrillation in the emergency department can be treated safely and effectively, avoiding admission. In the present study, we present the epidemiology and characteristics of atrial fibrillation patients presenting to the emergency department, as well as the impact of diverse management strategies on atrial-fibrillation-related hospital admissions. Lastly, the design and initial data of the HEROMEDICUS protocol will be presented, which constitutes an electrophysiology-based aggressive rhythm control strategy in patients with atrial fibrillation in the emergency department setting.
Keyphrases
- atrial fibrillation
- emergency department
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- healthcare
- percutaneous coronary intervention
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- randomized controlled trial
- adverse drug
- venous thromboembolism
- social media
- prognostic factors
- risk factors
- electronic health record
- patient reported outcomes
- coronary artery disease
- acute coronary syndrome
- patient reported